Serrano Gimaré M.
- Country
- Spain
- Department
- 200: Pediatric Neurology
Research Overview
Data & Insights
Has run more than one trial at 2 of 5 partner sites.
Specializations
Rare Genetic Disorders
The investigator specializes in treating rare genetic conditions, with particular emphasis on PMM2-CDG (Phosphomannomutase 2 - Congenital Disorder of Glycosylation) and its associated neurological manifestations.
- Ataxia management in PMM2-CDG
- Long-term therapeutic approaches
- Novel treatment evaluation
The research focus includes assessment of innovative therapeutic interventions for patients with glycosylation disorders.
Neurological Disorders
Dedicated to advancing treatment options for Angelman Syndrome, focusing on cognitive function improvement and developmental progression in pediatric patients.
- Cognitive function assessment
- Developmental disorder therapeutics
- Pediatric neurological conditions
The investigator evaluates novel therapeutic compounds targeting neurological symptom management in genetic disorders.
Clinical Pharmacology
Expertise in studying pharmacodynamics and pharmacokinetics of experimental treatments for rare genetic conditions.
- Safety and tolerability assessment
- Multiple-dose evaluation
- Long-term therapeutic monitoring
The investigator conducts comprehensive evaluations of drug safety profiles across different age groups.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.